Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorVanderbilt University Medical Center

About this trial

RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is looking at gastrointestinal biomarkers in tissue and biological fluid samples from patients and participants undergoing colonoscopy, endoscopy, or surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Undergoing colonoscopy or endoscopy for diagnostic or screening purposes at the Vanderbilt University Medical Center or at the Veterans Affairs Medical Center AND

Diagnosis of gastrointestinal (GI) cancer, polyps, or inflammatory bowel disease

History of previously treated GI cancer, polyps, or inflammatory bowel disease

Capable of giving informed consent

Disqualifiers

None

Trial population

Vanderbilt University Medical Center patients with GI malignancy

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Identification of new potential biomarkers of increased gastrointestinal cancer risk using tissue and biofluid samples from patients undergoing colonoscopy, endoscopy, or surgery

Genomic and proteomic biomarkers

Time frame
Through study completion, approximately 30 years
2

Development of new screening strategies based on substances found in tissue and biofluid samples

Genomic and proteomic biomarker discovery

Time frame
Through study completion, approximately 30 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Vanderbilt University Medical Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator